{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:04:10Z","timestamp":1779984250590,"version":"3.53.1"},"reference-count":35,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"unspecified","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2026,4,23]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The WHO Model Lists of Essential Medicines (MLEM and MLEMc) guide national medicine selection, particularly in low-income and lower middle-income countries (LMICs). Concerns exist about the adequacy and transferability of economic evidence supporting recent cancer medicine additions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically examined modifications to cancer medicines on the WHO MLEM(c) between 2017 and 2023 and assessed their adoption into National Essential Medicines Lists (NEMLs) and NEMLs for children (NEMLcs) of African LMICs (2019\u20132024). Economic evidence was classified as cost or cost-effectiveness data and transferability to African LMIC contexts was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 160 modifications, 11% included cost data and 9% cost-effectiveness evidence. All identified cost-effectiveness studies showed low transferability to African LMIC settings. Among 46 African LMICs, 23 NEMLs and 6 NEMLcs were available. Median adoption of new cancer medicines was 23% for NEMLs and 13% for NEMLcs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Recent WHO MLEM(c) modifications to cancer medicines are rarely supported by robust, context-specific economic evidence yet several have been adopted in African LMICs. Stronger requirements for economic evaluations are essential to ensure the affordability, sustainability and policy relevance of WHO essential medicine recommendations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgh-2025-022533","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:20:21Z","timestamp":1779981621000},"page":"e022533","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Weak economic evidence for WHO\u2019s essential cancer medicines for Africa"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7788-6765","authenticated-orcid":false,"given":"Aron E","family":"van der Steege","sequence":"first","affiliation":[{"name":"IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Humuza","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Economics and Management, University of Rwanda, Kigali, Rwanda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyprien","family":"Shyirambere","sequence":"additional","affiliation":[{"name":"Butaro Cancer Center of Excellence, Partners In Health, Burera, Rwanda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Hogerzeil","sequence":"additional","affiliation":[{"name":"Global Health Unit, Department of Health Sciences, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8364-2847","authenticated-orcid":false,"given":"Rob M P M","family":"Baltussen","sequence":"additional","affiliation":[{"name":"IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"2026052808201448000_11.5.e022533.1","unstructured":"Cotlear D , Nagpal S , Smith O , et al . Going universal: how 24 developing countries are implementing universal health coverage from the bottom up. Washington, DC World Bank; 2015. Available: https:\/\/documents1.worldbank.org\/curated\/en\/936881467992465464\/pdf\/99455-PUB-Box393200B-OUO-9-PUBDATE-9-28-15-DOI-10-1596-978-1-4648-0610-0-EPI-210610.pdf [accessed 24 Jul 2025]"},{"key":"2026052808201448000_11.5.e022533.2","unstructured":"United Nations . Transforming our world: the 2030 Agenda for sustainable development. 2015. Available: https:\/\/sustainabledevelopment.un.org\/content\/documents\/21252030%20Agenda%20for%20Sustainable%20Development%20web.pdf?ref%E2%80%89=%E2%80%89truth11.com [Accessed 24 Jul 2025]."},{"key":"2026052808201448000_11.5.e022533.3","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/S2214-109X(19)30463-2","article-title":"A comprehensive assessment of universal health coverage in 111 countries: a retrospective observational study","volume":"8","author":"Wagstaff","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2026052808201448000_11.5.e022533.4","unstructured":"World Health Organization . World health report 2013: research for universal health coverage. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/85761\/9789240690837_eng.pdf?sequence=2 [Accessed 24 Jul 2025]."},{"key":"2026052808201448000_11.5.e022533.5","unstructured":"World Health Organization . The selection and use of essential medicines. 2023."},{"key":"2026052808201448000_11.5.e022533.6","unstructured":"World Health Organization . WHO model lists of essential medicine. Available: https:\/\/www.who.int\/groups\/expert-committee-on-selection-and-use-of-essential-medicines\/essential-medicines-lists [Accessed 24 Jul 2025]."},{"key":"2026052808201448000_11.5.e022533.7","unstructured":"World Health Organization . WHO launches a digital version of its model list of essential medicines (EML). Available: https:\/\/www.who.int\/news\/item\/27-02-2020-who-launch-e-eml [Accessed 24 Jul 2025]."},{"key":"2026052808201448000_11.5.e022533.8","doi-asserted-by":"crossref","DOI":"10.1186\/s40545-023-00595-4","article-title":"Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation","volume":"16","author":"Brhlikova","year":"2023","journal-title":"J Pharm Policy Pract"},{"key":"2026052808201448000_11.5.e022533.9","first-page":"810","article-title":"Do prescribing formularies help GPs prescribe from a narrower range of drugs? A controlled trial of the introduction of prescribing formularies for NSAIDs","volume":"47","author":"Avery","year":"1997","journal-title":"Br J Gen Pract"},{"key":"2026052808201448000_11.5.e022533.10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1742-7843.2011.00682.x","article-title":"The \u2019wise list\u2019- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm","volume":"108","author":"Gustafsson","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2026052808201448000_11.5.e022533.11","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(24)01549-6","article-title":"WHO shapes priorities for medicines? An analysis of the applicants and decision makers within the historical evolution of the WHO Model Lists of Essential Medicines","volume":"404","author":"Jenei","year":"2024","journal-title":"Lancet"},{"key":"2026052808201448000_11.5.e022533.12","doi-asserted-by":"crossref","first-page":"e1860","DOI":"10.1016\/S2214-109X(22)00376-X","article-title":"Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward","volume":"10","author":"Jenei","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026052808201448000_11.5.e022533.13","unstructured":"UNICEF . Malaria. Available: https:\/\/data.unicef.org\/topic\/child-health\/malaria\/ [Accessed 24 Jul 2025]."},{"key":"2026052808201448000_11.5.e022533.14","unstructured":"Observatory IAH . AIDS is still a global public health threat\u2026. Available: https:\/\/files.aho.afro.who.int\/afahobckpcontainer\/production\/files\/iAHO-HIV_Regional_Factsheet_November2022.pdf [Accessed 24 Jul 2025]."},{"key":"2026052808201448000_11.5.e022533.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12939-023-01962-y","article-title":"Addressing cancer care inequities in sub-Saharan Africa: current challenges and proposed solutions","volume":"22","author":"Omotoso","year":"2023","journal-title":"Int J Equity Health"},{"key":"2026052808201448000_11.5.e022533.16","unstructured":"World Health Organization . Technical report: pricing of cancer medicines and its impacts: a comprehensive technical report for the World Health Assembly Resolution 70.12: operative paragraph 2.9 on pricing approaches and their impacts on availability and affordability of medicines for the prevention and treatment of cancer. 2018."},{"key":"2026052808201448000_11.5.e022533.17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S1470-2045(19)30459-0","article-title":"Improving affordability of new Essential Cancer Medicines","volume":"20","author":"\u2019t Hoen","year":"2019","journal-title":"Lancet Oncol"},{"key":"2026052808201448000_11.5.e022533.18","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.628744","article-title":"Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature","volume":"9","author":"Ocran Mattila","year":"2021","journal-title":"Front Public Health"},{"key":"2026052808201448000_11.5.e022533.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-023-09706-y","article-title":"Availability and affordability of anticancer medicines at cancer treating hospitals in Rwanda","volume":"23","author":"Rurangwa","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"2026052808201448000_11.5.e022533.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279817","article-title":"A comprehensive survey of cancer medicines prices, availability and affordability in Ghana","volume":"18","author":"Ocran Mattila","year":"2023","journal-title":"PLoS One"},{"key":"2026052808201448000_11.5.e022533.21","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac143"},{"key":"2026052808201448000_11.5.e022533.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077776","article-title":"Refocusing the World Health Organization\u2019s Model List of Essential Medicines on the needs of low and middle income countries","volume":"385","author":"Wirtz","year":"2024","journal-title":"BMJ"},{"key":"2026052808201448000_11.5.e022533.23","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.14.149914"},{"key":"2026052808201448000_11.5.e022533.24","unstructured":"World Health Organization . The selection and use of essential medicines. 2019."},{"key":"2026052808201448000_11.5.e022533.25","unstructured":"World Health Organization . The selection and use of essential medicines. 2021."},{"key":"2026052808201448000_11.5.e022533.26","unstructured":"World Health Organization . The selection and use of essential medicines. 2017."},{"key":"2026052808201448000_11.5.e022533.27","unstructured":"World Health Organization . Publications. Available: https:\/\/www.who.int\/publications\/i [Accessed 24 Jul 2025]."},{"key":"2026052808201448000_11.5.e022533.28","unstructured":"World Health Organization . The global health observatory. 2024. Available: https:\/\/www.who.int\/data\/gho\/data\/indicators"},{"key":"2026052808201448000_11.5.e022533.29","unstructured":"World Health Organization . Global health expenditure database. 2024. Available: https:\/\/apps.who.int\/nha\/database\/Select\/Indicators\/en"},{"key":"2026052808201448000_11.5.e022533.30","unstructured":"World Bank . Global Economic Monitor (GEM). 2023. Available: https:\/\/databank.worldbank.org\/source\/global-economic-monitor-(gem)"},{"key":"2026052808201448000_11.5.e022533.31","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1016\/S2214-109X(23)00162-6","article-title":"Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures","volume":"11","author":"Pichon-Riviere","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2026052808201448000_11.5.e022533.32","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/heapol\/czz119","article-title":"Access to medicines through health systems in low- and middle-income countries","volume":"34","author":"Ozawa","year":"2019","journal-title":"Health Policy Plan"},{"key":"2026052808201448000_11.5.e022533.33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/EDBK_100028","article-title":"An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on Access","volume":"41","author":"Leighl","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2026052808201448000_11.5.e022533.34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1377\/hlthaff.2024.00089","article-title":"Low- And Middle-Income Countries Experienced Delays Accessing New Essential Medicines, 1982-2024","volume":"43","author":"Wouters","year":"2024","journal-title":"Health Aff (Millwood)"},{"key":"2026052808201448000_11.5.e022533.35","unstructured":"Rwanda Ministry of Health . Health benefit package committee report on cancer assessment [unpublished report]. Kigali Ministry of Health; 2023."}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2025-022533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:20:27Z","timestamp":1779981627000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2025-022533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,28]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjgh-2025-022533"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2025-022533","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}